Ignite Creation Date:
2025-12-24 @ 11:38 PM
Ignite Modification Date:
2025-12-25 @ 9:28 PM
Study NCT ID:
NCT01497756
Status:
COMPLETED
Last Update Posted:
2020-02-26
First Post:
2011-12-20
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Feasibility Trial of the Circumferential Abdominal Pelvic Pressure Device (CAPP)
Sponsor:
University of New Mexico
Organization:
Study Overview
Official Title:
Feasibility Trial of the Circumferential Abdominal Pelvic Pressure Device (CAPP)
Status:
COMPLETED
Status Verified Date:
2020-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
A group of midwives and obstetric nurses have been trained to use circumferential abdominal pelvic pressure (CAPP) to treat postpartum hemorrhage. As part of the training follow up any use of a CAPP device will be monitored to identify complications.
Detailed Description:
Providers will be surveyed twice at 4 and 8 months using open ended methods.
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: